Modified Release Formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and Methods of Using the Same
US2013310430A1
Compositions and methods of using (r)-pramipexole
WO2013096870A1
Compositions and methods for treating amyotrophic lateral sclerosis
AU2012205273A1
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
WO2011150221A2
Compounds and methods of modulating mitochondrial bioenergetic efficiency through an interaction with atp synthase (complex v) and its subunits
BRPI1010084A2
Method to Treat Amyotrophic Lateral Sclerosis in a Patient
IL200926D0
Modified release formulations of (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazole-diamine and methods of using the same
CN102186350A
Compositions and methods of using (r)-pramipexole
EP2137171A2
Synthesis of chirally purified substituted benzothiazole diamines
CN101677564A
(6R)-4,5,6,7-tetrahydrochysene-N6-propyl group-2, the improvement delivery formulations and the using method thereof of 6-benzothiazole-diamines
CN102772404A
Compositions of (r)-pramipexole and methods of using the same
EP2497473A1
Therapeutically effective amounts of R(+) and S(-) pramipexole for use in the treatment of Parkinson's disease and pharmaceutical compositions thereof
EP2026803A2
Compositions of r(+) and s(-) pramipexole and methods of using the same
WO2007121188A2
Compositions and methods of using r(+) pramipexole
